Tirzepatide Semaglutide (Ozempic/Wegovy) activates GLP-1 receptors, which: Slows stomach emptying Reduces appetite Improves insulin sensitivity Typically results in 15-20% weight loss over a year Tirzepatide (Mounjaro/Zepbound) activates both GLP-1 and GIP receptors, which: Provides all semaglutide benefits May have stronger effects on glucose metabolism Often results in 20-25% weight loss over a year Sometimes has fewer gastrointestinal side effects Your optimal choice depends on your specific PCOS presentation
3 Immunohistochemistry of interleukin-1 (IL-1) in the dorsal root ganglion (DRG) and spinal cord (SC) at (A) 5 min (representative value of phase 1) and (B) 35 min (representative value of phase 2) Graph (bottom) represents the number of immunostained cells in the DRG and SC (mean SD)
But for microdosing protocols, where doses might be expressed as 12.5 units or 7.5 units, half-unit syringes become important
Traditionally, AD is tackled with drugs like acetylcholinesterase inhibitors (e.g., donepezil, galantamine, rivastigmine) (35) and the N-Methyl-D-Aspartate (NMDA) receptor allosteric modulator, memantine (68)
Liver fat reduction Retatrutide demonstrated remarkable effects on liver fat in a dedicated study published in Nature Medicine
The old practice of pulling back on the plunger to check for blood is unnecessary for subcutaneous injection
